Sector: Health Care
Director information for VIR BIOTECHNOLOGY INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Elliott Sigal | 74 | ["M.D.","Ph.D."] | [] | 2026 | |
| Elliott Sigal, M.D., Ph.D. | [] | ["Audit","Compensation"] | 2026 | ||
| George Scangos | Ph.D.+ | [] | ["Nominating and Corporate Governance"] | 2026 | |
| Janet Napolitano | 68 | [] | [] | 2026 | |
| Janet Napolitano, J.D. | [] | ["Audit","Compensation"] | 2026 | ||
| Jeffrey S. Hatfield | 68 | [] | [] | 2026 | |
| Jeffrey S. Hatfield, MBA | [] | ["Audit","Compensation"] | 2026 | ||
| Marianne De Backer | President, Chief Executive Officer and Director | 57 | ["M.Sc.","Ph.D.","MBA"] | [] | 2026 |
| Marianne De Backer | M.Sc., Ph.D., MBA | [] | [] | 2026 | |
| Norbert Bischofberger | 70 | ["Ph.D."] | [] | 2026 | |
| Norbert Bischofberger, Ph.D. | [] | ["Audit","Nominating and Corporate Governance"] | 2026 | ||
| Ramy Farid | 61 | ["Ph.D."] | [] | 2026 | |
| Ramy Farid, Ph.D. | [] | ["Audit","Science and Technology"] | 2026 | ||
| Robert More | 58 | [] | [] | 2026 | |
| Robert More, MBA | [] | ["Audit","Compensation"] | 2026 | ||
| Robert Nelsen | MBA+ | [] | ["Nominating and Corporate Governance"] | 2026 | |
| Saira Ramasastry | 50 | [] | [] | 2026 | |
| Saira Ramasastry, M.S. | M.Phil. | [] | [] | 2026 | |
| Vicki Sato, Ph.D. | Board Chair | [] | ["Audit","Compensation"] | 2026 |
